scispace - formally typeset
R

Rodrigo Portes Ureshino

Researcher at Federal University of São Paulo

Publications -  41
Citations -  6381

Rodrigo Portes Ureshino is an academic researcher from Federal University of São Paulo. The author has contributed to research in topics: Autophagy & Neuroprotection. The author has an hindex of 18, co-authored 34 publications receiving 5569 citations. Previous affiliations of Rodrigo Portes Ureshino include University of São Paulo & University of Cambridge.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Nicotinic acid adenine dinucleotide phosphate (NAADP) regulates autophagy in cultured astrocytes

Gustavo J.S. Pereira, +12 more
- 12 Aug 2011 - 
TL;DR: It is shown that intracellular delivery of NAADP evokes Ca2+ signals from acidic organelle formation and levels of the autophagic markers, LC3II and beclin-1, and that these signals are potentiated upon overexpression of TPCs.
Journal ArticleDOI

Calcium Signaling Alterations, Oxidative Stress, and Autophagy in Aging

Rodrigo Portes Ureshino, +4 more
- 09 Jun 2014 - 
TL;DR: Data is presented that may depict an expanded view of molecular aging theories, beginning with the idea that reactive oxygen species (ROS) are the major effectors in this process, and the importance of autophagy as a neuroprotective mechanism.
Journal ArticleDOI

Autophagy and intermittent fasting: the connection for cancer therapy?

Fernanda Antunes, +7 more
- 10 Dec 2018 - 
TL;DR: Nutritional restriction is a promising protocol to modulate autophagy and enhance the efficacy of anticancer therapies while protecting normal cells and the possibility of using fasting as an adjuvant therapy for cancer treatment, as well as the molecular mechanisms underlying this approach.
Journal ArticleDOI

Felodipine induces autophagy in mouse brains with pharmacokinetics amenable to repurposing

Farah H. Siddiqi, +20 more
- 18 Apr 2019 - 
TL;DR: It is demonstrated that felodipine, an anti-hypertensive drug, can induce autophagy and clear a variety of aggregated neurodegenerative disease-associated proteins in mouse brains at plasma concentrations similar to those that would be seen in humans taking the drug.